Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2561]

Early-onset gastrointestinal cancers show more advanced disease and wider...

Dr Jessica Paulus - Ontada, Boston, USA

Early-onset gastrointestinal cancers show more advanced disease and wider racial survival gaps ( Dr Jessica Paulus - Ontada, Boston, USA )

Xaluritamig plus abiraterone shows promising anti-tumour activity with...

Dr David Pook - Monash Health, Melbourne, Australia

Xaluritamig plus abiraterone shows promising anti-tumour activity with manageable safety in chemotherapy-naïve mCRPC ( Dr David Pook - Monash Health, Melbourne, Australia )

Tarlatamab improves brain metastases control and survival compared to chemo in...

Dr Giannis Mountzios - The University of Athens, Athens, Greece

Tarlatamab improves brain metastases control and survival compared to chemo in SCLC ( Dr Giannis Mountzios - The University of Athens, Athens, Greece )

Mezigdomide plus carfilzomib and dexamethasone delays disease progression in R...

Dr Paul Richardson - Dana-Farber Cancer Institute, Boston, USA

Mezigdomide plus carfilzomib and dexamethasone delays disease progression in R/R multiple myeloma ( Dr Paul Richardson - Dana-Farber Cancer Institute, Boston, USA )

Mobile app-based symptom monitoring helps maintain quality of life in advanced...

Prof Wendy Chan - The University of Hong Kong, Pok Fu Lam, Hong Kong

Mobile app-based symptom monitoring helps maintain quality of life in advanced cancer ( Prof Wendy Chan - The University of Hong Kong, Pok Fu Lam, Hong Kong )

Daraxonrasib nearly doubles survival in previously treated metastatic...

Dr Brian Wolpin - Dana-Farber Cancer Institute, Boston, USA

Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancer ( Dr Brian Wolpin - Dana-Farber Cancer Institute, Boston, USA )

Yoga improves mood, fatigue, and insomnia in cancer survivors following...

Dr Karen Mustian - Wilmot Cancer Institute, Rochester, USA

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment ( Dr Karen Mustian - Wilmot Cancer Institute, Rochester, USA )

Lorlatinib delivers 7-year progression-free survival and durable brain control...

Prof Tony Mok - Chinese University of Hong Kong, Ma Liu Shui, Hong Kong

Lorlatinib delivers 7-year progression-free survival and durable brain control in ALK+ NSCLC ( Prof Tony Mok - Chinese University of Hong Kong, Ma Liu Shui, Hong Kong )

Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancer

Dr Adam Kibel - Dana-Farber Cancer Institute, Boston, USA

Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancer ( Dr Adam Kibel - Dana-Farber Cancer Institute, Boston, USA )

Abemaciclib shows benefit in dedifferentiated liposarcoma

Dr Mark Dickson - Memorial Sloan Kettering Cancer Center, New York, USA

Abemaciclib shows benefit in dedifferentiated liposarcoma ( Dr Mark Dickson - Memorial Sloan Kettering Cancer Center, New York, USA )

Adjuvant selpercatinib reduces recurrence in RET-positive lung cancer

Dr Jonathan W. Goldman - University of California Los Angeles, Los Angeles, USA

Adjuvant selpercatinib reduces recurrence in RET-positive lung cancer ( Dr Jonathan W. Goldman - University of California Los Angeles, Los Angeles, USA )

Low-dose pembrolizumab plus chemotherapy improves survival and expands access...

Dr Nandini Menon - Tata Memorial Centre, Mumbai, India

Low-dose pembrolizumab plus chemotherapy improves survival and expands access in advanced NSCLC ( Dr Nandini Menon - Tata Memorial Centre, Mumbai, India )

More from ecancer